CV Prof. Dr. Michael Kracht
|
Professional career |
||
| since 2007 | W3 Professorship for Pharmacology and Toxicology and Managing Director of the Rudolf Buchheim Institute of Pharmacology of the Justus Liebig University Giessen |
|
| 2007 | Specialist for Pharmacology and Toxicology | |
| 2005 | Professorship W2 for Molecular mechanisms of cytokine-mediated gene regulation at the Hannover Medical School (MHH) | |
| 2002 | Extraordinary Professorship at the Hannover Medical School (MHH) | |
| 1999 | Venia Legendi for the subject Molecularpharmacology at the MHH, title of the work: Molekulare Mechanismen der Entzündung: MAP Kinase Kinase 7 (MKK7) und stressaktivierte/Jun-NH2-terminale Proteinkinasen (SAPK/JNK) bilden ein zentrales Effektormodul bei der Signaltransduktion des pro-inflammatorischen Zytokins Interleukin-1 | |
| 1995-2005 | Academic Assistent and group leader at the Institute of Pharmacology, MHH | |
| 1992-1995 | Post-doc as part of a Wellcome European Travelling Fellowship in the laboratory of Dr. J. Saklatvala, Strangeways Research Laboratory, Cambridge and AFRC Babraham Institute, Babraham, Great Britain, subject: Charakterisierung und Identifizierung durch Interleukin-1 induzierte Zytosolische Serin/Threonin Proteinkinasen |
|
| 1990-1992 | Post-Doc as a part of a DFG Post-doc scholarship in the working group of Prof. Dr. med. Marta Szamel at the Institute of Molecular Pharmacology, MHH, leader: Prof. Dr. med. Klaus Resch, subject: Untersuchungen zur Aktivierung von Proteinkinase C durch Interleukin-1 in T-Lymphozyten |
|
| 1988-1990 | Doctor in internship and later assistance doctor at the hospital for Unfall-, Gefäß- und Abdominalchirurgie, leader: Prof. Dr. med. K. Reichel, Städtisches Krankenhaus Siloah, Hannover | |
| 1989 | Graduation Dr. med. at the Hannover Medical School (MHH) | |
| 1986-1987 | Experimental graduation at the Institute for Molecular Pharmacology of MHH, title of the work: Molekulare Mechanismen der Signalübertragung in T-Lymphozyten. Die Rolle des Calciums und der Diglyceride bei der IL 2 Rezeptorexpression, der IL 2 Produktion und der Proliferation |
|
| 1981-1988 | Study of human medicine at the Hannover Medical School (MHH) | |
|
Memberships and Functions |
||
| 2020- | Project leader in the Research Training Group GRK 2573 The inflammatory tumor secretome – from understanding to novel therapies, Marburg |
|
| 2019- | Faculty member of the excellence cluster Cardio-Pulmonary Institute (CPI), Giessen | |
| 2018-2020 | Board member of the Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V. (DGPT) |
|
| 2018- | Member of the International Max Planck Research School for Heart and Lung Research (IMPRS-HLR Faculty), Bad Nauheim |
|
| 2016-2024 | Project leader in the DFG Clinical Research Group KFO 309 Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies, Giessen |
|
| 2016- | Project leader in the DFG Collaborative Research Center SFB 1213 Pulmonary Hypertension and Cor Pulmonale, Giessen |
|
| 2013- | Project leader in the DFG Collaborative Research Center SFB 1021 RNA viruses: RNA metabolism, host response and pathogenesis, Marburg |
|
| 2011- | Member of Deutsches Zentrum für Lungenforschung (DZL) | |
| 2010- | Project leader in the DFG Collaborative Research Center TRR 81 Chromatin Changes in Differentiation and Malignancies, Giessen |
|
| 2010- | Faculty member of UGMLC Universities of Giessen and Marburg Lung Center | |
| 2009- | Faculty member of ECCPS Excellence Cluster Cardio-Pulmonary System, Giessen | |
| 1998- | Member of Signal Transduction Society (STS) | |
| 1998- | Member of Deutsche Gesellschaft für Immunologie (DGFI) | |
| 1996- | Member of Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V. (DGPT) |
|
Reviewer for Immunity, Cell Reports., Nat Commun., Sci Rep., Sci Signal., Proc Natl Acad Sci U S A., Trends Biochem Sci., EMBO J., J Biol Chem., J Cell Biol., Trends Immunol., Oncogene., Nucleic Acids Res., Br J Pharmacol., PLoS One.,
J Leukocyte Biol., Exp Cell Research., Mol Med., Mol Cell Biochem., FEBS Letters, FEBS J., Biol Chem.,
Int J Cancer., Front Immunol., Blood, Cells.
Associate Editor for Naunyn Schmiedebergs Arch Pharmacol.
Associate Editor for Front Immunol.
Reviewer for Deutsche Forschungsgemeinschaft (DFG), Medical Research Council (MRC, UK), Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., Deutsche Krebsstiftung, Cancer Research UK, Arthritis Research UK, Science Foundation Ireland (SFI), APART (Austrian Programme for Advanced Research and Technology), Deutsches Krebsforschungszentrum (DKFZ), Reumafonds (NL), Alexander von Humboldt-Stiftung, Stichting tegen Kanker (Belgium)
Honours and Awards
2008 Genomic Pioneer Award, awarded on 30.09.2008 by Ocimum Biosolutions
at HUGO's International Genome Meeting held at Hyderabad, India
2008 Dolph Adams award of the Journal of Leukocyte Biology for the most highly
cited review article of years 2002-2007
The Dolph Adams Award and the state of the Journal of Leukocyte Biology
1998 Young Investigator Award 1998, 1. price, International Cytokine Society on the occasion of the "Second Joint Meeting of the International Cytokine Society (ICS) and the International Society for Interferon and Cytokine Research (ISICR)", Jerusalem, Israel